Medication info

Durozide Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Spironolactone›25mg / 1 tabletHydrochlorothiazide›25mg / 1 tablet
Manufacturer / importer
Austin Pharmaceuticals Co., Ltd.
Appearance
Pale yellow circular tablet.
Packaging
1000 tablets/bottle
Approval status
Expired

MFDS item code 200102026 · Notified 2001.03.13

This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of edema (e.g., due to heart failure or cirrhosis), essential hypertension, and diuretic-induced hypokalemia
Who takes it
Adults · Children
Adult dose
The optimal dose is determined according to each patient's response to the drug. 1. Edema (congestive heart failure, cirrhosis, nephrotic syndrome) The adult maintenance dose is 100mg each of spironolactone and hydrochlorothiazide per day, administered orally as a single dose or in divided doses. Depending on the response to the initial dose, 25-200mg of each may be administered. In some cases, adding spironolactone or hydrochlorothiazide tablets to this medicine may be desirable for appropriate treatment. 2. Essential hypertension Adults: Administer 50-100mg each of spironolactone and hydrochlorothiazide per day orally, as a single dose or in divided doses. The amount of spironolactone in this medicine is usually sufficient to minimize potassium loss caused by hydrochlorothiazide; therefore, potassium supplements are not needed when this medicine is used long-term for hypertension or for edema. Adjust the dose as appropriate according to age and symptoms.
Child dose
The pediatric daily maintenance dose is 1.65-3.3mg per kg of body weight.

Ingredients

Manufacturer
Austin Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of edema (e.g., due to heart failure or cirrhosis), essential hypertension, and diuretic-induced hypokalemia

  • Edema symptoms
  • congestive heart failure
  • edema
  • sodium retention symptoms
  • hypokalemia
  • abdominal swelling
  • liver cirrhosis
  • nephrotic syndrome
  • essential hypertension
  • hypokalemia
View approved original text

This medication is primarily used to treat edema caused by various conditions such as congestive heart failure, liver cirrhosis, and nephrotic syndrome. It is particularly beneficial when other treatment methods are ineffective or inappropriate. Additionally, it can be used in cases of essential hypertension that are difficult to control with other treatments. This medicine helps to reduce the excessive accumulation of sodium and fluid in the body, improving edema symptoms and assisting in blood pressure regulation. It is used to effectively alleviate the patient's symptoms and improve their condition.

How to take

Adult dose

The optimal dose is determined according to each patient's response to the drug. 1. Edema (congestive heart failure, cirrhosis, nephrotic syndrome) The adult maintenance dose is 100mg each of spironolactone and hydrochlorothiazide per day, administered orally as a single dose or in divided doses. Depending on the response to the initial dose, 25-200mg of each may be administered. In some cases, adding spironolactone or hydrochlorothiazide tablets to this medicine may be desirable for appropriate treatment. 2. Essential hypertension Adults: Administer 50-100mg each of spironolactone and hydrochlorothiazide per day orally, as a single dose or in divided doses. The amount of spironolactone in this medicine is usually sufficient to minimize potassium loss caused by hydrochlorothiazide; therefore, potassium supplements are not needed when this medicine is used long-term for hypertension or for edema. Adjust the dose as appropriate according to age and symptoms.

Child dose

The pediatric daily maintenance dose is 1.65-3.3mg per kg of body weight.

Precautions

This medication contains spironolactone, which has been associated with tumor formation in animal studies; therefore, it should only be used for indicated conditions, and unnecessary use should be avoided. Adjustments are needed depending on the patient's condition when treating hypertension and edema; thus, it is not suitable for initial treatment. Concurrent use with potassium-rich medications or foods may dangerously elevate potassium levels; therefore, co-administration should be avoided. In patients with poor liver function, there is a risk of coma due to fluid and electrolyte imbalance; thus, careful administration is required. Concurrent use with lithium preparations may decrease lithium excretion and increase toxicity, so co-administration should be avoided. Calcium channel blockers may enhance the effects of other antihypertensive medications and may provoke allergic reactions in patients with a history of allergies or asthma. Additionally, some sulfonamide derivatives may exacerbate systemic lupus erythematosus, thus caution is advised. This medication should not be administered to patients with anuria, acute renal failure or severe renal impairment, hyperkalemia, acute or severe liver failure, those taking potassium-sparing diuretics, or those with a hypersensitivity to sulfonamide drugs. This medication contains lactose and should be avoided in patients with lactose intolerance. Patients taking this drug may have an increased risk of non-melanoma skin cancer; therefore, they should minimize sun exposure and regularly check their skin condition. Patients allergic to the yellow No. 5 ingredient in this drug should also exercise caution. This medication may cause various side effects, including dizziness, hypotension, gastrointestinal issues, blood abnormalities, allergic reactions, electrolyte imbalances, muscle cramps, neuropsychiatric symptoms, etc. Special attention should be given to patients with renal function abnormalities or liver dysfunction. During treatment, electrolyte levels in the blood should be regularly monitored to check for abnormalities, and if symptoms of hyperkalemia arise, medical advice should be sought immediately. Pregnant or breastfeeding women should consult a doctor regarding the use of this medication, as it may affect the fetus or newborn. Safety in children has not been established, thus caution is needed when prescribing this drug. In case of overdose, emergency measures such as inducing vomiting or gastric lavage are necessary, and since electrolyte imbalances and central nervous system depression may occur, immediate medical attention should be sought. This drug may interact with other medications, so it is essential to inform the healthcare provider of any other medications being taken, especially when taking digoxin, loop diuretics, corticosteroids, or alcohol.

Side effects

  • Weakness
  • orthostatic hypotension
  • hypotension
  • pancreatitis
  • jaundice
  • diarrhea
  • vomiting
  • sialadenitis
  • convulsions
  • constipation
Show 60 more
  • gastric irritation
  • nausea
  • loss of appetite
  • increased blood lipid levels
  • aplastic anemia
  • agranulocytosis
  • leukopenia
  • hemolytic anemia
  • thrombocytopenia
  • anaphylactic reactions
  • necrotizing vasculitis
  • pneumonia
  • pulmonary edema
  • dyspnea
  • photosensitivity
  • fever
  • urticaria
  • rash
  • purpura
  • electrolyte imbalance
  • hyperglycemia
  • diabetes
  • hyperuricemia
  • hypokalemia
  • muscle cramps
  • dizziness
  • asthenia
  • headache
  • anxiety
  • renal failure
  • abnormal kidney function
  • interstitial nephritis
  • erythema multiforme
  • itching
  • pemphigus-like lesions
  • transient blurred vision
  • xanthopsia
  • sensory disturbances
  • acute respiratory distress syndrome
  • gastric bleeding
  • ulcers
  • gastritis
  • gynecomastia
  • erectile dysfunction
  • menstrual irregularities
  • amenorrhea
  • postmenopausal bleeding
  • hirsutism
  • low pitch of the voice
  • mental confusion
  • ataxia
  • drowsiness
  • mixed cholestatic hepatotoxicity
  • fever
  • urticaria
  • papular skin rash
  • erythematous skin rash
  • mental confusion
  • ataxia
  • drowsiness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from entering. It is recommended to keep it at a temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication over time.

Appearance and packaging

Appearance

Pale yellow circular tablet.

Package unit

1000 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.